Phase Ib study of eltrombopag and azacitidine in patients with high-risk myelodysplastic syndromes and related disorders (the ELASTIC study) (2022)

First Author: Sternberg A
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/bjh.18389

PubMed Identifier: 35918828

Publication URI: http://europepmc.org/abstract/MED/35918828

Type: Journal Article/Review

Parent Publication: British Journal of Haematology

Issue: 2

ISSN: 0007-1048